Still time to tell us your experience of how innovation is adopted in the NHS
We need your views; complete the DECIDE Survey by September 30th
Decisions in health Care to Introduce or Diffuse Innovations using Evidence (or DECIDE) – is a major study investigating the role of evidence in decisions to introduce innovation.
We are seeking the views of people working in the NHS.
We want to know
- what different types of evidence are used when making decisions to adopt or diffuse innovations in the NHS?
- what is your experience of decision-making in the NHS when it comes to spreading innovation?
Taking part in this survey is voluntary. No personal details will be asked of you in this survey, and published reports about this survey will not contain any personal details
The survey should take no more than 10 minutes to complete.
Pinkie Chambers, a senior pharmacist at UCLH and former CLAHRC HEE NCEL Fellow is celebrating success in securing a prestigious NIHR Fellowship award.
After spending a year with the CLAHRC to hone her research skills, and against stiff competition, Pinkie secured a Doctoral Research Fellowship (DRF), which offers 3 years full-time funding (or 4 or 5 years part-time) to undertake a PhD.
The DRF is aimed at individuals, of outstanding potential, early in their research careers.
The Fellowship scheme aims to fast-track them through a customised research training programme in an environment reflecting their individual talents and training needs.
It is anticipated that successful applicants would become independent research leaders within 6 to 10 years of completing the DRF award.
During her year with us as a CLAHRC/HEE NCEL Fellow Pinkie developed her skills and worked on her application to the NIHR.
Her areas of interest include improving the chemotherapy pathway for cancer patients, and supporting patients to self-administer some of their blood tests to avoid hospital visits.
As well as her work as a Senior pharmacist at UCLH, Pinkie is also Joint Chair of the London Cancer Chemotherapy Expert Reference Group.
In particular Pinkie was commended by the NIHR for her efforts to involve patients and the public in her work which were described as “exceptional” – thanks in no small part to the CLAHRC’ Research Advisory Panel who Pinkie worked with during her CLAHRC/HEE NCEL Fellowship and who she presented to twice.
Read more about Pinkie’s time with us here
Our congratulations to Pinkie and best wishes for her future career